CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

Middle East respiratory syndrome coronavirus (MERS-CoV), a novel infectious agent causing severe respiratory disease and death in humans, was first described in 2012. Antibodies directed against the MERS-CoV spike (S) protein are thought to play a major role in controlling MERS-CoV infection and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Veit, Svenja, Jany, Sylvia, Fux, Robert, Sutter, Gerd, Volz, Asisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316859/
https://www.ncbi.nlm.nih.gov/pubmed/30558354
http://dx.doi.org/10.3390/v10120718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316859/
https://www.ncbi.nlm.nih.gov/pubmed/30558354
http://dx.doi.org/10.3390/v10120718

Ejemplares similares